NCT07326007 Verbal Analgesia Versus Standard Technique for Pain Control During Copper T380A Intrauterine Device Insertion in Women With Previous Cesarean Delivery
| NCT ID | NCT07326007 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Cairo University |
| Condition | Contraception |
| Study Type | INTERVENTIONAL |
| Enrollment | 88 participants |
| Start Date | 2025-10-02 |
| Primary Completion | 2026-02-15 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 88 participants in total. It began in 2025-10-02 with a primary completion date of 2026-02-15.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Insertion of copper IUDs is often associated with moderate pain, which may reduce acceptance and continuation rates. Factors such as nulliparity and absence of prior vaginal delivery are known to increase pain perception. Women who have delivered only by cesarean section represent a special subgroup because their cervix has not undergone vaginal dilation and cervical remodeling, making insertion technically more difficult and often more painful. This group has been underrepresented in prior analgesia trials, highlighting an important evidence gap.
Eligibility Criteria
Inclusion Criteria: * Women aged 18-45 years. * Desire for Copper T380A IUD. * Delivery history limited to cesarean section(s), no vaginal delivery Exclusion Criteria: * o Current pelvic infection, cervicitis, or vaginitis. * Uterine anomalies or fibroids distorting the cavity. * Contraindication to copper IUD procedure, and use of any analgesic medication within the last 6-8 hours prior to insertion. * Pregnancy or suspected pregnancy. * Severe dysmenorrhea requiring narcotics
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07326007 clinical trial?
This trial is open to female participants only, aged 18 Years or older, up to 45 Years, studying Contraception. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07326007 currently recruiting?
Yes, NCT07326007 is actively recruiting participants. Contact the research team at mahmoudalalfy@ymail.com for enrollment information.
Where is the NCT07326007 trial being conducted?
This trial is being conducted at Giza, Egypt.
Who is sponsoring the NCT07326007 clinical trial?
NCT07326007 is sponsored by Cairo University. The trial plans to enroll 88 participants.